Azitra, Inc. (AZTR) stock
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.57−0.04 (-6.20%)
Close on Nov 18, 2026Market cap $34.56MP/E –Yield –
Azitra operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Azitra's operating income for the twelve months ending Jun 30, 2026 was -$12.35M. For fiscal 2025 it was -$10.97M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.97M | – |
| FY2024 | Dec 31, 2024 | -$10.99M | – |
| FY2023 | Dec 31, 2023 | -$7.45M | – |
| FY2022 | Dec 31, 2022 | -$9.45M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.42M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.93M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.77M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.93M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.66M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.96M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.47M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.99M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.09M | – |
See a number that looks wrong?